sCR1sLe(X) ameliorates ischemia/reperfusion injury in experimental lung transplantation

Journal of Thoracic and Cardiovascular Surgery

Volumn 120, Issue 6, 2000, Pages 1078-1084

  Stammberger, Uz ^a   Hamacher, Jürg ^a,b   Hillinger, Sven ^a,c   Schmid, Ralph A ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; SELECTIN; COMPLEMENT INHIBITOR; COMPLEMENT RECEPTOR; SOLUBLE COMPLEMENT INHIBITOR 1; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ARTICLE; CELL ADHESION; CELL MIGRATION; ENZYME ACTIVITY; INTRACARDIAC THROMBOSIS; ISCHEMIA; LEUKOCYTE ADHERENCE; LIGAND BINDING; LIPID PEROXIDATION; LUNG INJURY; LUNG PARENCHYMA; LUNG TRANSPLANTATION; MALE; NEUTROPHIL; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RAT; RECIPIENT; REPERFUSION; REPERFUSION INJURY; ALLOTRANSPLANTATION; ANIMAL; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; FISCHER 344 RAT; IMMUNOLOGY; LEUKOCYTE; MOUSE; PATHOLOGY; TIME;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATOR PROTEINS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; LEUKOCYTES; LIPID PEROXIDATION; LUNG TRANSPLANTATION; MALE; MICE; NEUTROPHILS; RATS; RATS, INBRED F344; RECEPTORS, COMPLEMENT; REPERFUSION INJURY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033622525     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2000.111175     Document Type: Article

References (23)

1. Early and long-term functional outcomes in unilateral, bilateral, and living-related transplant recipients
2. Reduction of conjugated dienes in lung transplantation: Effect of BN 52021
3. Donor administration of PAF antagonist (TCV-309) enhances lung preservation
4. Future horizons of lung preservation by application of a platelet-activating factor antagonist compared with current clinical standards: Euro-Collins flush perfusion versus donor core cooling
5. Expression of endothelin-1 and effects of an endothelin receptor antagonist, TAK-044, at reperfusion after cold preservation in a canine lung transplantation model
6. Recombinant glycoproteins that inhibit complement activation and also bind the selectin adhesion molecules
7. Simplified rat lung transplantation using a cuff technique
8. Safe lung preservation for twenty-four hours with Perfadex
9. Lidocaine reduces reperfusion injury and neutrophil migration in canine lung allografts
10. Measurement of protein using bicinchoninic acid
11. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
12. Soluble complement receptor type 1 (CD35) in bronchoalveolar lavage of inflammatory lung diseases
13. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors
14. Soluble human complement receptor type I: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
15. Protective effects of soluble CRI in complement- and neutrophil-mediated tissue injury
16. Effect of soluble complement receptor type 1 on reperfusion edema and neutrophil migration after lung allotransplantation in swine
17. Complement inhibition attenuates human lung transplant reperfusion injury: A multicenter trial
18. Effect of oligosaccharides on rejection and reperfusion injury after lung transplantation
19. Attenuation of rat lung isograft reperfusion injury with a combination of anti-ICAM-1 and anti-beta2 integrin monoclonal antibodies
20. Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation
21. Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts
22. Reduction of myocardial infarct size with sCR1sLex, an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x.
23. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein